Covidien PLC COV reported a 47% rise in its FQ3 net profit.
Covidien's quarterly net profit surged to $535 million, or $1.07 per share, from $364 million, or $0.72 per share, in the year-ago period. Its revenue climbed 14% to $2.93 billion. Covidien's adjusted earnings per share gained to $1.01 from $0.85 per share. Analysts were expecting earnings of $0.95 per share on revenue of $2.86 billion.
Covidien shares gained 0.28% to $50.39 in after-hours trading.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in